W. L. Ranitz-Greven

External applicability of SGLT2 inhibitor cardiovascular outcome trials to patients with type 2 diabetes and cardiovascular disease

H. Nathoe, L. Kappelle, G. D. de Borst, 2021, Cardiovascular Diabetology.

High Glycaemic Variability is Associated with Worse Diabetes- related Well-being in Type 2 Diabetes Patients on Insulin Therapy, an Observational Study

H. W. Valk, D. Biesma, J. Beulens, 2016 .